BLCO — BAUSCH + LOMB CORP (Healthcare >> Medical Instruments & Supplies)
BLCO FAQ
What is BLCO's P/E ratio?
BAUSCH + LOMB CORP (BLCO) currently trades at a P/E ratio of -94.70.
What is BLCO's ROE?
BAUSCH + LOMB CORP reports a Return on Equity (ROE) of -3.43%.
What is BLCO's dividend yield?
BAUSCH + LOMB CORP offers a dividend yield of 0.00%.
What is BLCO's Deepscope Quality Score?
Deepscope rates BLCO's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy BLCO?
Deepscope's AI Timing Score for BLCO is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does BLCO belong to?
BAUSCH + LOMB CORP is classified under the Healthcare >> Medical Instruments & Supplies sector on the NYSE exchange.
|
USD 15.46
Price
0.11
(0.72%)
Day Change
|
|
|---|
BLCO Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...
| Yếu tố Chất lượng |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 15.46 |
| PBV / Sector |
0.85 / 4.41
GREAT
|
| Earning Per Share | -0.62 |
| PE / Sector |
N/A / 36.90
|
| PEG or PE/Growth / Sector |
0.06 / -0.97
GREAT
|
| Average 1M Daily Value |
7.34 M
|
| Average 1W Daily Value |
9.48 M
|
| Yếu tố Kỹ thuật |
|
28% |
| Sức khỏe tài chính |
|
45% |
| Khả năng kiếm lợi nhuận |
|
56% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-06 09:08:24 |
| Symbol | BLCO |
| Name | BAUSCH + LOMB CORP |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NYSE |
| Listed Shares | 356.54 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 5,492.44 / 16,249.68 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 520 Applewood Crescent, Vaughan, ON, Canada, L4K 4B4
Phone: 905 695 7700
Website: https://www.bausch.com
Employees: 13,000
Description: Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
Google